Compare XOMAP & MCGAU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | XOMAP | MCGAU |
|---|---|---|
| Founded | N/A | N/A |
| Country | United States | United States |
| Employees | 13 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Blank Checks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | N/A | N/A |
| IPO Year | N/A | 2025 |
| Metric | XOMAP | MCGAU |
|---|---|---|
| Price | $25.86 | $10.28 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 717.0 | ★ 5.5K |
| Earning Date | N/A | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $24.96 | $8.40 |
| 52 Week High | $27.11 | $11.25 |
| Indicator | XOMAP | MCGAU |
|---|---|---|
| Relative Strength Index (RSI) | 42.14 | 51.45 |
| Support Level | $25.53 | $10.23 |
| Resistance Level | $25.97 | $10.31 |
| Average True Range (ATR) | 0.11 | 0.02 |
| MACD | -0.00 | 0.00 |
| Stochastic Oscillator | 20.11 | 80.00 |
XOMA Royalty Corp is a biotechnology royalty aggregator playing a role in helping biotech companies achieve their goal of improving human health. XOMA acquires the potential future economics associated with pre-commercial therapeutic candidates that have been licensed to pharmaceuticals or biotechnology companies. XOMA acquires future economic rights, the seller receives non-dilutive, non-recourse funding that can use to advance their internal drug candidate(s) or for general corporate purposes. Geographically, the company operates in Switzerland, United States, Asia Pacific, Europe and Others.